An abstract is unavailable. This article is available as a PDF only.doi:10.1097/00006324-200212001-00486Chalmers, RobinBegley, CarolynOptometry and Vision Science
Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes M Lemp - 《Clao J》 被引量: 0发表: 1995年 Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Age-Related Macular Degeneration Patient-reported measures of visual functio...
Patients treated with 30 mg 3 times daily for 12 weeks reported improvement in global evaluation of dry eyes vs placebo-treated patients (P = .0453). Patients with the most persistent and troublesome dry eyes had the highest rate of improvement (43% and 26% of the most severely affected ...
Long-term observations of patients treated with voretigene neparvovec will help elucidate the reactive processes that occur in the retina in response to newly increased metabolic activity, and aid in the improvement of gene therapies for the RPE-related genes. 2.3.2 AAV-miniCEP290 (Iveric Bio)...
Intravitreous Anti-Vascular Endothelial Growth Factor Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk Learn more here:https://clinicaltrials.gov/ct2/show/NCT02634333 A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ra...
Artificial tears, lacrimal punctum embolization, and local immunosuppressants are used to treat the dry eyes symptoms associated with cGVHD. However, the overall effectiveness is still inadequate; there are some side effects and the course of treatment is lengthy and expensive. Therefore, clinicians ...
March 27 - AlmataBio:Avalo Therapeutics agreed to hand over $22 million in stock and cash to acquire AlmataBio, but Avalo only has eyes for Almata's anti-IL-1β monoclonal antibody AVTX-009. As a result, none of Almata's employees will be keeping their job under the new owner...
Artificial tears, lacrimal punctum embolization, and local immunosuppressants are used to treat the dry eyes symptoms associated with cGVHD. However, the overall effectiveness is still inadequate; there are some side effects and the course of treatment is lengthy and expensive. Therefore, clinicians ...
Patients should be questioned about a history of periorbital trauma, thyroid disease, recurrent edema, dry eye syndrome, dry mouth, kidney disease, and dermatologic conditions. [12, 13, 2] Next: Physical What to Read Next on Medscape Related Conditions and Diseases Pterygium Anterior Segment...
Severe dry eyes (keratoconjunctivitis sicca) (such as from Sjogren's syndrome, chronic graft versus host disease, radiation, surgery, meibomian gland deficiency);or Corneal disorders associated with systemic autoimmune diseases (rheumatoid arthritis, dermatological disorders such as atopic, epidermolysis bull...